is a Managing Director in Cambridge, MA, USA.
Prior to joining Novartis Venture Fund, he worked at the Novartis Institutes for BioMedical Research as the Director of Special Projects. Campbell is a New Zealand-trained physician and worked as a Medical House Officer at Auckland Hospital. He is a Kauffman Fellow and holds an MBA from Harvard Business School and an MPP (public policy) from the John F. Kennedy School of Government, where he was a Knox Fellow and Rotary Ambassadorial Scholar.
Exits: Akebia Therapeutics, Inc. (NASDAQ: AKBA)
Euthymics Bioscience, Inc. (Board Seat)
Galera Therapeutics, Inc. (Board Seat)
ImaginAB, Inc. (Board Seat)
Neurovance, Inc. (Board Seat)